According to an international research team, a new type of gene variant could influence fasting blood glucose levels via melatonin metabolism . The gene is closely associated with increased blood glucose levels and a higher risk of type 2 diabetes .
The new finding could potentially enhance diabetes treatment possibilities, taking treatment horizons beyond currently used symptomatic therapy approaches for diabetes treatment .
To reach their conclusions, the MAGIC Consortium (Meta Analyses of Glucose and Insulin -related traits Consortium) analysed data from 13 difference case-control studies, with over 18,000 diabetic participants.
The results of the study were published in the January issue of journal Nature Genetics .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…